Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Substance misuse of gabapentin.

Literature DB >> 22867659

Substance misuse of gabapentin.

Blair H Smith, Cassie Higgins, Alex Baldacchino, Brian Kidd, Jonathan Bannister.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2012 PMID： 22867659 PMCID： PMC3404313 DOI： 10.3399/bjgp12X653516

Source DB: PubMed Journal: Br J Gen Pract ISSN： 0960-1643 Impact factor: 5.386

× No keyword cloud information.

2 in total

1. The evidence for pharmacological treatment of neuropathic pain.

Authors: Nanna Brix Finnerup; Søren Hein Sindrup; Troels Staehelin Jensen
Journal: Pain Date: 2010-09 Impact factor: 6.961

2. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.

Authors: Nicola Torrance; Blair H Smith; Michael I Bennett; Amanda J Lee
Journal: J Pain Date: 2006-04 Impact factor: 5.820

2 in total

20 in total

Review 1. Abuse and Misuse of Pregabalin and Gabapentin.

Authors: Kirk E Evoy; Megan D Morrison; Stephen R Saklad
Journal: Drugs Date: 2017-03 Impact factor: 9.546

Review 2. Misuse and abuse of pregabalin and gabapentin: cause for concern?

Authors: Fabrizio Schifano
Journal: CNS Drugs Date: 2014-06 Impact factor: 5.749

3. Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.

Authors: Damien Driot; Emilie Jouanjus; Stéphane Oustric; Julie Dupouy; Maryse Lapeyre-Mestre
Journal: Br J Clin Pharmacol Date: 2019-03-28 Impact factor: 4.335

Review 4. Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.

Authors: Martin J Brodie
Journal: CNS Drugs Date: 2017-02 Impact factor: 5.749

5. Gabapentin misuse.

Authors: Robin Lennox; Dee Mangin
Journal: CMAJ Date: 2019-01-14 Impact factor: 8.262

Review 6. Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization.

Authors: Kenneth Blum; M C Gondré-Lewis; E J Modestino; L Lott; D Baron; D Siwicki; T McLaughlin; A Howeedy; M H Krengel; M Oscar-Berman; P K Thanos; I Elman; M Hauser; L Fried; A Bowirrat; R D Badgaiyan
Journal: Mol Neurobiol Date: 2019-05-23 Impact factor: 5.590

Substance misuse of gabapentin.

1. The evidence for pharmacological treatment of neuropathic pain.

2. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.

Review 1. Abuse and Misuse of Pregabalin and Gabapentin.

Review 2. Misuse and abuse of pregabalin and gabapentin: cause for concern?

3. Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.

Review 4. Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.

5. Gabapentin misuse.

Review 6. Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization.

7. Risk to heroin users of polydrug use of pregabalin or gabapentin.

8. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.

Review 9. Gabapentin misuse, abuse and diversion: a systematic review.

10. Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice.